Pharmacokinetic Selectivity
Pharmacokinetic Selectivity is a pharmacological property that refers to the differential distribution, metabolism, and elimination of a drug among distinct tissues or organs, enabling preferential exposure in target over non-target sites through inherent differences in absorption, protein binding, transport mechanisms, or clearance rates.
56
Publications
2K
Citations
486
Authors
113
Institutions
Publications per year
2017–2026
16
Parents
56
Braj B. Lohray, Vidya Bhushan Lohray, Ashok C. Bajji et al. · Journal of Medicinal Chemistry · 2001 · 136 citations
Pharmacokinetics, Absorption and Tissue Distribution of Tanshinone IIA Solid Dispersion
Haiping Hao, Guangji Wang, Nan Cui et al. · Planta Medica · 2006 · 77 citations
Su Young Jung, Sun-Jin Hwang, Jeffery M. Clarke et al. · Investigational New Drugs · 2019 · 76 citations
Medicine, Oncology, Pharmacokinetics +13
1–5 of 56
486
2
h-index
2
h-index
2
h-index
2
h-index
1
h-index
1–5 of 486
113

China Pharmaceutical University
Nanjing, China
4 h-index
31 publications
1.1K citations
AstraZeneca (United Kingdom)
Cambridge, United Kingdom
3 h-index
37 publications
2K citations
Kyoto Pharmaceutical University
Kyoto, Japan
2 h-index
6 publications
127 citations
Israel Institute for Biological Research
Ness Ziona, Israel
2 h-index
8 publications
168 citations
Molecular Biology Consortium
Chicago, United States
1 h-index
1 publications
16 citations

Chongqing University
Chongqing, China
1 h-index
3 publications
42 citations
Indian Institute of Technology Kharagpur
Kharagpur, India
1 h-index
2 publications
36 citations
Ebara (Japan)
Tokyo, Japan
1 h-index
3 publications
48 citations
1–8 of 113
8 publications · 390 citations
8
h-index
Repository · 4 publications · 110 citations
4
h-index
2 publications · 69 citations
2
h-index
BJ · 2 publications · 42 citations
2
h-index
2 publications · 144 citations
2
h-index
1–5